UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$591M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$493M |
| 3 |
Broadcom
AVGO
|
+$481M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$460M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$503M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$368M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$279M |
| 5 |
Fidelity National Information Services
FIS
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.13% |
| 2 | Financials | 7.1% |
| 3 | Healthcare | 6% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Industrials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
BioMarin Pharmaceuticals
BMRN
$12.4B
| $8.91M | ﹤0.01% |
92,452
-152,805
| -62% | -$13.5M |
|
|
AEL
2202
DELISTED
American Equity Investment Life Holding Company
AEL
| $8.9M | ﹤0.01% |
159,467
-54,866
| -26% | -$2.98M |
|
2203
Fastly Inc
FSLY
$3.66B
| $8.84M | ﹤0.01% |
496,842
+171,991
| +53% | +$2.9M |
|
2204
PUT
Wayfair
W
$14.6B
| $8.82M | ﹤0.01% |
143,000
+133,000
| +1,330% | +$6.95M |
|
2205
PUT
Abercrombie & Fitch
ANF
$5B
| $8.82M | ﹤0.01% |
100,000
| – | – |
|
2206
Antero Midstream
AM
$10.1B
| $8.82M | ﹤0.01% |
704,032
-118,865
| -14% | -$1.5M |
|
2207
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.23B
| $8.82M | ﹤0.01% |
271,142
+3,085
| +1% | +$93.7K |
|
2208
Nuveen California Municipal Value Fund
NCA
$302M
| $8.8M | ﹤0.01% |
982,058
-43,371
| -4% | -$363K |
|
|
SKX
2209
DELISTED
Skechers
SKX
| $8.8M | ﹤0.01% |
141,139
+20,703
| +17% | +$1.12M |
|
2210
Revolution Medicines
RVMD
$44B
| $8.79M | ﹤0.01% |
306,558
+209,399
| +216% | +$5.03M |
|
2211
NNN REIT
NNN
$8.99B
| $8.78M | ﹤0.01% |
203,631
-861,420
| -81% | -$33.4M |
|
2212
PUT
Okta
OKTA
$25.8B
| $8.77M | ﹤0.01% |
+96,900
| New | +$7.39M |
|
2213
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.33B
| $8.76M | ﹤0.01% |
718,628
-68,528
| -9% | -$793K |
|
2214
Encompass Health
EHC
$12.4B
| $8.75M | ﹤0.01% |
131,089
-43,369
| -25% | -$2.81M |
|
2215
Janus International
JBI
$757M
| $8.71M | ﹤0.01% |
667,639
-18,270
| -3% | -$194K |
|
|
BBBY
2216
CALL
Bed Bath & Beyond
BBBY
$442M
| $8.69M | ﹤0.01% |
345,070
+235,070
| +214% | +$4.05M |
|
2217
Selective Insurance
SIGI
$5.73B
| $8.68M | ﹤0.01% |
87,302
+13,237
| +18% | +$1.36M |
|
2218
PUT
AstraZeneca
AZN
$250B
| $8.68M | ﹤0.01% |
64,450
| – | – |
|
2219
Invesco S&P International Developed Low Volatility ETF
IDLV
$348M
| $8.68M | ﹤0.01% |
307,976
+276,292
| +872% | +$7.35M |
|
|
SMAR
2220
DELISTED
Smartsheet Inc.
SMAR
| $8.67M | ﹤0.01% |
181,234
+67,878
| +60% | +$2.89M |
|
2221
BlackRock Flexible Income ETF
BINC
$16.3B
| $8.67M | ﹤0.01% |
+165,778
| New | +$8.42M |
|
2222
Invesco S&P SmallCap Low Volatility ETF
XSLV
$249M
| $8.66M | ﹤0.01% |
196,057
-44,434
| -18% | -$1.81M |
|
2223
PUT
KB Home
KBH
$3.59B
| $8.61M | ﹤0.01% |
137,800
| – | – |
|
2224
CALL
Conagra Brands
CAG
$7.23B
| $8.6M | ﹤0.01% |
300,000
| – | – |
|
2225
PUT
Lamb Weston
LW
$7.19B
| $8.59M | ﹤0.01% |
+79,500
| New | +$7.66M |
|
Similar funds
UBS Group's Q4 2023 Portfolio in Review
As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.
- UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
- UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
- UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
- UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
- UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
- UBS Group opened 1,223 new positions and closed 1,397 in Q4 2023.
- UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.